IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

[Bionews] Event: Unlock Insight from Your Clinical Data

amatern via bionews%40net.bio.net (by amatern from gmail.com)
Thu Sep 13 19:18:47 EST 2007


Event: Unlock Insight from Your Clinical Data
Presenters Info:  Hai Hu, Senior Director of Biomedical Informatics,
Windber Research Institute

Michael N. Liebman, Ph.D., Executive Director, Windber Research
Institute & President and Managing Director, Strategic Medicine, Inc

Mick Correll, Director Clinical Solutions, InforSense

Host: Dave Menninger, VP Marketing & Product Management, InforSense
Date: 19 September 2007
Time: 11:00 ET (New York)
Duration: 1 hour including Q&A

>From academic medical research centers to hospitals and health
insurers, the healthcare industry continues to improve its
capabilities for electronic data capture. Despite these advances, a
gap remains in the ability of these IT systems to deliver knowledge
and insight back to the very researchers and clinicians they are built
to support.

Please join Dr. Hai Hu from the Windber Research Institute to learn
about some of the tools and techniques he and his colleagues are using
to bridge this gap and deliver insight to their clinical community.

In this webcast you will learn how to:

Move beyond primary data capture systems to an analytical environment
Explore patient populations: trend identification, hypothesis
generation, and cohort analysis
Make the most of longitudinal patient records and investigate temporal
relationships of life and medical events
Integrate patient and sample information to enhance tissue
Who should attend:

Clinical and biomedical researchers
Data analysts and informaticians
Medical and scientific officers
Healthcare IT managers

About InforSense
InforSense Ltd., the leader in embedded enterprise analytics, enables
organizations to orchestrate and optimize their business-critical
decision-making processes.  Leading pharmaceutical and biotechnology,
consumer goods, healthcare, financial services manufacturing and
communications companies are using the company's flagship product,
InforSense, to enhance productivity by embedding analytics within
their business processes.  The company is privately held, with
European headquarters in London, UK and North American headquarters in
Cambridge, Massachusetts.

About Windber Research Institute
The Windber Research Institute is a translational medicine research
center that focuses on bringing the problems in the clinic back to the
research laboratory for analysis at the genomic, proteomic, image and
informatic levels. It is focused in its research areas on women's
health, including obstetrics and gynecologic diseases including
breast, ovarian, endometrial and cervical cancers, cardiovascular
disease, obesity and diabetes, and processes of normal aging including
menopause. It has worked closely with its partners at InforSense to
develop an integrated research environment that is being extended to
support physician decision making in collaboration with the patient.
Major efforts in tissue banking, patient data acquisition and genomic
research (sequencing, genotyping, gene expression, whole genome
analysis) and proteomics (protein separation and identification)
comprise the experimental focus. The biomedical informatics efforts
include data modelling and warehousing, data mining and research into
the development of disease models for risk assessment, prevention and
early detection, including environmental and lifestyle factors.

Windber Research Institute collaborates closely with the Walter Reed
Army Medical Center and with the Joyce Murtha Breast Care Center, the
University of Pittsburgh Medical Center and Cancer Institute,
Georgetown University, and the University of California-San Francisco
in the areas of women's health, cardiovascular disease and obesity. It
is a private, non-profit research institute that is located
approximately 1.5 hours from Pittsburgh, Pennsylvania, in the Laurel
Highlands Mountains.
Additional information can be obtained at www.wriwindber.org.

About Strategic Medicine, Inc
Strategic Medicine, Inc (SMI) is an emerging healthcare company
focused on translational medicine that will capitalize on the broad
trend in healthcare information technology to integrate patient
medical information to facilitate better clinical decisions, assess
and improve quality of care, share information among hospital
communities to improve outcomes, and provide rich clinical information
to pharmaceutical companies for drug development and clinical
candidate selection. SMI defines translational medicine as working
with clinicians to identify real diagnostic and therapeutic problems,
moving them into the research environment, and providing solutions
through data analysis that are immediately applicable to improving the
quality of care in the clinic. By merging clinical, molecular and
imaging data, in a patient-centric data model that is longitudinally
focused, while accessing a unique tissue repository, SMI is developing
one of the first systems that can lead to viable translational and
preventive medicine as a true clinical opportunity.

SMI is uniquely positioned in this evolving market. In association
with the Windber Research Institute and its partners, the Company has
developed a flexible and scaleable Internet-based data system that
enables hospitals and hospital networks to realize near term data
security, productivity and quality of care improvements, while paving
the way for clinical trial participation, and the long term benefits
of a truly interoperable, patient centric, personalized health
Additional information can be obtained at www.strategicmedicine.com

For questions on the webcast please e-mail information from inforsense.com

InforSense Ltd
Colet Court,
100 Hammersmith Road,
London, W6 7JP
United Kingdom  InforSense - North America
155 Second Street,
Cambridge, MA 02141


If you would no longer like to receive InforSense information via
email, please unsubscribe.

©2007 InforSense Ltd. All rights reserved. InforSense, the InforSense
logo and TextSense are registered trademarks of InforSense Ltd. Open
Discovery Workflow is a trademark of InforSense Ltd. All other brands
or products names are trademarks of their respective holders.

More information about the Bionews mailing list

Send comments to us at biosci-help [At] net.bio.net